EV2 Technologies, a University of Pittsburgh spinout developing biodegradable devices to treat vascular disease, is the newest tenant at BenchBridge Labs, located in the Hot Metal Labs building at 700 Tech Drive on Hot Metal Campus. EV2 Technologies is part of the Soft Tissue Biomechanics (STB) Lab.
Pitt researchers Ali Behrangzade, Jonathan Vande Geest, William Wagner and John Pacella founded EV2 to build the next generation of endovascular treatments for stenotic vascular disease, a condition in which blood vessels narrow and restrict blood flow. Behrangzade leads the company as CEO.
“Our vision is to advance a new generation of endovascular treatments for stenotic vascular disease, addressing this unmet clinical need through a differentiated approach designed to overcome the limitations and shortcomings of existing treatment options.”
At BenchBridge, the team joins a growing community of life sciences companies turning Pittsburgh research into real-world care.